Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens

Hepatology

Volumn 33, Issue 6, 2001, Pages 1533-1543

  Urbani, Simona ^a   Uggeri, Jacopo ^a   Matsuura, Yoshiharu ^b   Miyamura, Tatsuo ^c   Penna, Amalia ^a   Boni, Carolina ^a   Ferrari, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS ANTIGEN;

ADENOVIRUS; ADULT; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE STRUCTURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LIVER CELL DAMAGE; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; VIRUS GENE;

EID: 0034992878     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.25091     Document Type: Article

References (46)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. To C or not to C: These are questions
3. Roles of ab and gd T cell subsets in viral immunity
4. Molecular mechanism of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
5. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
6. Patients with chronic hepatitis C have circulating cyto-toxic T cells which recognize hepatitis C virus encoded peptides binding to HLA-A2.1 molecule
7. Cytotoxic T lymphocyte response to hepatitis C virus derived peptides containing the HLA-A2.1 binding motif
8. CTL Responses of HLA-A2.1-transgehic mice specific for hepatits C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
9. HLA class I restricted cytotoxic T lymphocytes specific for hepatitis C virus: Identification of multiple epitopes and characterization of patterns of cytokines release
10. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patient
11. Quantitative analysis of the peripheral blood CTL response in patients with chronic HCV infection
12. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
13. Liver derived CTL in hepatitis C virus infection: Breadth and specificity of responses in a cohort of persons with chronic infection
14. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
15. Identification of HLA-A3 and B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C
16. Analysis of successful immune responses in persons infected with hepatitis C virus
17. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
18. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs
19. DNA vaccination for the induction of immune responses against hepatitis C virus proteins
20. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus
21. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model
22. DNA immunization of mice find macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
23. Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
24. Efficient generation of recombinant adenoviruses using adenovirus NA-terminal protein complex and a cosmid bearing the full-length genome
25. Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus
26. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes
27. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
28. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
29. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen
30. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein
31. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody
32. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein
33. A structure based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets
34. HLA class I restricted cytotoxic T cells in acute viral hepatitis type B
35. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
36. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
37. Degradation of cell proteins and generation of MHC class I-presented peptides
38. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: Determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC)
39. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
40. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
41. Stringent allele/epitope requirements for MART-1/Melan A immunodominance: Implications for peptide-based immunotherapy
42. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus
43. Detection of diverse hepatitis C virus (HCV)specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
44. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein
45. Immunodominance in major histocompatibility complex class-I restricted T lymphocyte responses
46. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome